Review
Pharmacology & Pharmacy
Koichiro Kuwahara
Summary: Natriuretic peptides, such as ANP and BNP, are important in cardioprotection in heart failure by antagonizing the effects of angiotensin II, while CNP plays a role in regulating vascular tone and blood pressure. These peptides are also being studied for their potential as biomarkers and therapeutics in cardiovascular disease.
PHARMACOLOGY & THERAPEUTICS
(2021)
Review
Chemistry, Analytical
Olga A. Goryacheva, Tatiana D. Ponomaryova, Daniil D. Drozd, Alina A. Kokorina, Tatiana Yu Rusanova, Pradyumna K. Mishra, Irina Yu Goryacheva
Summary: Rapid assessment of biomarker levels in patients is an effective approach in the diagnosis and treatment of heart failure. BNP and NT-proBNP, as biomarkers of HF, have a high negative predictive value and are particularly useful in excluding HF as a cause of non-specific symptoms.
TRAC-TRENDS IN ANALYTICAL CHEMISTRY
(2022)
Article
Physiology
Walter Calderon-Gerstein, Astrid Bruno-Huaman, Milagros Damian-Mucha, Lizet Huayllani-Flores
Summary: This study aimed to evaluate the effectiveness of BNP values for HF diagnosis in a high-altitude population. Results showed that BNP values above 100 pg/mL had low specificity for HF diagnosis, and a cut-off point of >=130 pg/mL is proposed to increase specificity.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY
(2021)
Article
Multidisciplinary Sciences
Sureeporn Wongjard, Pongsakorn Aiemderm, Kanchana Monkhang, Kittitat Jaengwang, Lueacha Tabtimmai, Charoenkwan Kraiya, Kiattawee Choowongkomon, Napachanok Mongkoldhumrongkul Swainson
Summary: Heart failure is a common global disease with significant symptoms. This study developed a diagnostic tool for heart failure by identifying a specific scFv that binds to the heart failure biomarker NT-proBNP. The scFv showed high binding efficiency and specificity, providing a promising solution for the reliable diagnosis of heart failure.
Review
Medicine, General & Internal
Gianmarco Alcidi, Giovanni Goffredo, Michele Correale, Natale Daniele Brunetti, Massimo Iacoviello
Summary: BNP and NT-proBNP play a key role as serum biomarkers in the management of heart failure. They can be used for diagnosis, prognostic stratification, monitoring and guiding therapy of HF, as well as evaluating the efficacy of new therapeutic strategies. However, their use is still limited due to the controversy surrounding their use in different clinical settings.
JOURNAL OF CLINICAL MEDICINE
(2022)
Article
Biochemistry & Molecular Biology
Ryuji Okamoto, Ryotaro Hashizume, Noboru Suzuki, Rie Ito, Tomoko Tokuhara, Hiroshi Fujiwara, Ye Zhe, Hiromasa Ito, Takaya Abe, Kaoru Dohi
Summary: The elevated BNP in patients with heart failure with preserved ejection fraction (HFpEF) is partly due to increased expression of iBNP from the heart. The iBNP-to-BNP ratio is higher in HFpEF compared to heart failure with reduced ejection fraction (HFrEF), and is associated with factors such as age, hemoglobin, calcium channel blocker (CCB) usage, and deceleration time.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Medicine, General & Internal
Kirsty Luo-Yng Tay, Abdel Rahman Osman, Esyn Ee Xin Yeoh, Jasmine Luangboriboon, Jie Fei Lau, Joanne Jia An Chan, Majed Yousif, Benjamin Yi Hong Tse, Graham Horgan, David T. Gamble, Phyo Kyaw Myint
Summary: The existing systematic reviews have not fully described the differences in cardiac and renal effects between ultrafiltration and diuretics as methods of decongestion in acute decompensated heart failure. This meta-analysis aimed to investigate the impact of ultrafiltration compared to diuretics on prognostic cardiac and renal biomarkers. A total of 10 randomized trials were included in the analysis, and the results showed no significant difference between ultrafiltration and diuretics in terms of cardiac and renal biomarkers, except for short-term blood urea nitrogen which showed a statistically higher increase with ultrafiltration. Overall, ultrafiltration has a similar impact as diuretic therapy on prognostic cardiac and renal biomarkers.
JOURNAL OF CLINICAL MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Andrea K. Roalfe, Sarah L. Lay-Flurrie, Jose M. Ordonez-Mena, Clare R. Goyder, Nicholas R. Jones, F. D. Richard Hobbs, Clare J. Taylor
Summary: This study reported contemporary trends in NP testing and HF diagnosis rates in adult patients in England from 2004-18. It found that NP testing in primary care has increased over time, with most patients with HF still not having an NP test recorded prior to diagnosis.
EUROPEAN HEART JOURNAL
(2022)
Article
Medical Laboratory Technology
Jooyoung Cho, Jong-Han Lee, Sang-Guk Lee
Summary: This study compared the analytical and clinical performance of 3 NT-proBNP immunoassays. The Atellica IM NT-proBNP assay showed acceptable analytical performance, while the Elecsys proBNP II assay may be more suitable for diagnosing heart failure.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
(2023)
Article
Cardiac & Cardiovascular Systems
Dong-Mei Li, Bin-Xin Li, Li-Jie Yang, Peng Gao, Zhong-Yu Ma, Zhong-Juan Li
Summary: The combination of miR-208a with NT-proBNP may provide a more reliable method for diagnosing HFrEF patients, showing higher AUC, sensitivity, and specificity compared to using NT-proBNP alone.
Review
Biochemistry & Molecular Biology
Riccardo Sarzani, Massimiliano Allevi, Chiara Di Pentima, Paola Schiavi, Francesco Spannella, Federico Giulietti
Summary: Cardiac natriuretic peptides are true hormones produced by cardiomyocytes, exerting systemic effects and contributing to cardiovascular health. They also have paracrine and autocrine activities on the heart, preventing cardiac dysfunction and promoting heart protection.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2022)
Review
Pharmacology & Pharmacy
Bruria Hirsh Raccah, Bar Biton, Offer Amir, Israel Gotsman, Dean Nahman, Ilan Matok
Summary: This meta-analysis assessed the efficacy of anti-remodeling cardiac therapy for Duchenne muscular dystrophy cardiomyopathy (DMDCM). The results showed that pharmacologic treatment can decrease heart rate, improve left ventricular ejection fraction, and potentially reduce total mortality.
FRONTIERS IN PHARMACOLOGY
(2022)
Article
Cardiac & Cardiovascular Systems
Emil Wolsk, Brian Claggett, Rafael Diaz, Kenneth Dickstein, Hertzel C. Gerstein, Lars Kober, Eldrin F. Lewis, Aldo P. Maggioni, John J. McMurray, Jeffrey L. Probstfield, Matthew C. Riddle, Scott D. Solomon, Jean-Claude Tardif, Marc A. Pfeffer
Summary: Serial NP measurements can improve the prediction of imminent cardiovascular death or heart failure hospitalization in patients with coronary artery disease and type 2 diabetes. The absolute risk estimates provided can aid clinicians in decision-making and help patients understand their short-term risk profile.
JOURNAL OF THE AMERICAN HEART ASSOCIATION
(2022)
Review
Biochemistry & Molecular Biology
Vittoriano Della Corte, Gaetano Pacinella, Federica Todaro, Rosaria Pecoraro, Antonino Tuttolomondo
Summary: Natriuretic peptides are a complex molecular network with pleiotropic effects on various organs and tissues, primarily maintaining cardiovascular homeostasis and regulating water-salt balance. Increasing knowledge of their receptors, molecular mechanisms, and discovery of new peptides has led to a better understanding of their physiological and pathophysiological roles, with potential therapeutic applications.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
(2023)
Article
Pharmacology & Pharmacy
Gaidaa M. Dogheim, Ibtsam Khairat, Gamal A. Omran, Sahar M. El-Haggar, Ahmed M. El Amrawy, Rehab H. Werida
Summary: This study evaluated the short-term effect of ivabradine on heart failure patients and found that ivabradine therapy can reduce levels of NT-Pro BNP and neopterin, which are biomarkers associated with heart failure. These biomarker levels showed a significant correlation with heart rate.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
(2022)